The effect of syrup simplex concentration on the physicochemical stability of Gembili’s inulin (Dioscorea esculenta (Lour.) Burkill) nanosilver colloid
DOI:
https://doi.org/10.12928/pharmaciana.v14i2.26569Keywords:
nanosilver, simplex syrup, immunostimulant, gembili’s inulinAbstract
Gembili tuber's inulin is a successful bioreductor agent that forms a nanosilver with a size of 481.4 nm and is stable for 30 days at 4 °C storage. That nanosilver has immunomodulatory activity and is proven safe from the results of acute toxicity tests at a dose of 4 mg/kgBB. However, a drug delivery system is needed to be developed as a supplement product. The syrup was chosen because it is free of alcohol, has a better taste, measured dose, and stability of the active substance compared to elixir, solution, and suspension. Simplex syrup as a syrup base affects stability because it has the potential to form crystals during storage. This research aims to determine the effect of simplex syrup concentration on the stability of nanosilver syrup. The research was conducted with the biosynthesis process using gembili's inulin, nanosilver characteristic, modified syrup formula, and stability test. Nanosilver syrup was prepared by modifying the simplex syrup concentration of 20%, 40%, and 60%. Nanosilver was added at 4 mg/KB b.w, then tested the physicochemical; stability, including organoleptic, pH, and viscosity, before and after storage with temperature variations of 4 °C and 40 °C for six cycles. The best formula then analysis of sugar reduction content and FT-IR. Data analysis using SPSS 21.0 Windows with One-way ANOVA test, Post Hoc, and Paired T-Test. The results showed that the concentration of simplex syrup affected consistency, pH, and viscosity. The simplex syrup concentration of 60% met the requirement with a medium thick consistency, pH 5.25±0.03, a viscosity of 92±2.6 cps, reducing sugar content was 20.59% ±0.002, and the FTIR profile showed that it still contained nanosilver which was indicated by the presence of Ag-N groups compared to silver nitrate solution.
Downloads
Published
Issue
Section
License
Authors who publish with Pharmaciana agree to the following terms:
- Authors retain copyright and grant the journal the right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC BY-SA 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.